Korean J Pathol.
2000 Apr;34(4):264-272.
Correlation of Expression of E-Cadherin, alpha-Catenin, beta-Catenin, and Clinicopathologic
Parameters in Colorectal Adenocarcinomas
- Affiliations
-
- 1Department of Pathology, College of Medicine, Chung-Ang University, Seoul 100-272, Korea.
Abstract
-
The E-cadherin, alpha-catenin, and beta-catenin expressions were immunohistochemically
investigated in paraffin-embedded materials of 80 cases of colorectal adenocarcinomas. The
staining similar to normal colorectal mucosa with preserved strong membranous staining pattern
was considered normal or preserved expression. The X2 test was used to analyse the statistical
correlation of cadherin/catenin expression with clinicopathologic parameters and the Breslow test
for the correlation with survival length. Normal colorectal mucosa showed strong membranous
expression of cadherin/catenin complex. The reduced E-cadherin, alpha-catenin, and beta-catenin
expression were found in 53/80 (66.3%), 46/80 (57.5%), and 44/80 (55.5%) cases of colorectal
cancers examined, respectively. There were significant correlations between E- cadherin and alpha
-catenin (p=0.035), and between alpha-catenin and beta-catenin (p=0.013). The reduced E-cadherin
expression was associated with histologic dedifferentiation, tumor depth, lymph node metastasis,
clinical stage (p<0.05), poor clinical outcome in stage II (p=0.016) and the reduced alpha-catenin
expression with lymph node metastasis and clinical stage (p<0.05). Reduced expression of two or
more proteins was correlated with lymph node matastasis, histologic dedifferentiation, clinical
stage, and survival (p<0.05). The present study demonstrates a significant down-regulation of
E-cadherin and alpha-catenin expression in colorectal cancer is associated with tumor invasiveness,
histologic dedifferentiation, lymph node metastasis, and clinical stage. These results suggest that
E-cadherin and alpha-catenin may be useful markers of invasiveness, lymph node metastatic
potential, and clinical stage and of value as prognostic markers in the earlier stage. Further
studies are needed to confirm the prognostic value of these cadherin/catenin complex.